These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 11964938)

  • 1. Impact of missing data due to selective dropouts in cohort studies and clinical trials.
    Touloumi G; Pocock SJ; Babiker AG; Darbyshire JH
    Epidemiology; 2002 May; 13(3):347-55. PubMed ID: 11964938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of missing data due to drop-outs on estimators for rates of change in longitudinal studies: a simulation study.
    Touloumi G; Babiker AG; Pocock SJ; Darbyshire JH
    Stat Med; 2001 Dec; 20(24):3715-28. PubMed ID: 11782028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of missing data due to dropouts on estimates of the treatment effect in a randomized trial of antiretroviral therapy for HIV-infected individuals. Canadian HIV Trials Network A002 Study Group.
    Raboud JM; Montaner JS; Thorne A; Singer J; Schechter MT
    J Acquir Immune Defic Syndr Hum Retrovirol; 1996 May; 12(1):46-55. PubMed ID: 8624760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estimation and comparison of rates of change in longitudinal studies with informative drop-outs.
    Touloumi G; Pocock SJ; Babiker AG; Darbyshire JH
    Stat Med; 1999 May; 18(10):1215-33. PubMed ID: 10363341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Missing covariates in longitudinal data with informative dropouts: bias analysis and inference.
    Roy J; Lin X
    Biometrics; 2005 Sep; 61(3):837-46. PubMed ID: 16135036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Accounting for dropout reason in longitudinal studies with nonignorable dropout.
    Moore CM; MaWhinney S; Forster JE; Carlson NE; Allshouse A; Wang X; Routy JP; Conway B; Connick E
    Stat Methods Med Res; 2017 Aug; 26(4):1854-1866. PubMed ID: 26078357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Which individuals make dropout informative?
    Geskus RB
    Stat Methods Med Res; 2014 Feb; 23(1):91-106. PubMed ID: 22534427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictive value of quantitative plasma HIV RNA and CD4+ lymphocyte count in HIV-infected infants and children.
    Palumbo PE; Raskino C; Fiscus S; Pahwa S; Fowler MG; Spector SA; Englund JA; Baker CJ
    JAMA; 1998 Mar; 279(10):756-61. PubMed ID: 9508151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Visit-driven endpoints in randomized HIV/AIDS clinical trials: impact of missing data on treatment difference measured on summary statistics.
    Le Corfec E; Chevret S; Costagliola D
    Stat Med; 1999 Jul; 18(14):1803-17; discussion 1819. PubMed ID: 10407251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple imputation compared with some informative dropout procedures in the estimation and comparison of rates of change in longitudinal clinical trials with dropouts.
    Ali MW; Siddiqui O
    J Biopharm Stat; 2000 May; 10(2):165-81. PubMed ID: 10803723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Robust analysis of biomarker data with informative missingness using a two-stage hypothesis test in an HIV treatment interruption trial: AIEDRP AIN503/ACTG A5217.
    Messer K; Vaida F; Hogan C
    Contemp Clin Trials; 2006 Dec; 27(6):506-17. PubMed ID: 16962381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of age at seroconversion and baseline HIV RNA level on the loss of CD4+ cells among persons with hemophilia. Multicenter Hemophilia Cohort Study.
    Touloumi G; Hatzakis A; Rosenberg PS; O'Brien TR; Goedert JJ
    AIDS; 1998 Sep; 12(13):1691-7. PubMed ID: 9764790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Accounting for dropout bias using mixed-effects models.
    Mallinckrodt CH; Clark WS; David SR
    J Biopharm Stat; 2001; 11(1-2):9-21. PubMed ID: 11459446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interpreting treatment differences when patients drop out of a clinical trial.
    Lindsey JC; McGrath NM
    AIDS Patient Care STDS; 1998 Apr; 12(4):275-85. PubMed ID: 11361954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of dropout from care among HIV-infected patients initiating antiretroviral therapy at a public sector HIV treatment clinic in sub-Saharan Africa.
    Asiimwe SB; Kanyesigye M; Bwana B; Okello S; Muyindike W
    BMC Infect Dis; 2016 Feb; 16():43. PubMed ID: 26832737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dropouts and missing data in psychiatric clinical trials.
    Potkin SG; Siu CO
    Am J Psychiatry; 2009 Nov; 166(11):1295; author reply 1295-6. PubMed ID: 19884237
    [No Abstract]   [Full Text] [Related]  

  • 17. Mixtures of varying coefficient models for longitudinal data with discrete or continuous nonignorable dropout.
    Hogan JW; Lin X; Herman B
    Biometrics; 2004 Dec; 60(4):854-64. PubMed ID: 15606405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How should we deal with missing data in clinical trials involving Alzheimer's disease patients?
    Coley N; Gardette V; Cantet C; Gillette-Guyonnet S; Nourhashemi F; Vellas B; Andrieu S
    Curr Alzheimer Res; 2011 Jun; 8(4):421-33. PubMed ID: 21244348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Variability in serial CD4 counts and relation to progression of HIV-I infection to AIDS in haemophilic patients. Transfusion Safety Study Group.
    Aledort LM; Hilgartner MW; Pike MC; Gjerset GF; Koerper MA; Lian EY; Lusher JM; Mosley JW
    BMJ; 1992 Jan; 304(6821):212-6. PubMed ID: 1346752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parametric models for incomplete continuous and categorical longitudinal data.
    Kenward MG; Molenberghs G
    Stat Methods Med Res; 1999 Mar; 8(1):51-83. PubMed ID: 10347860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.